More than two dozen cannabis testing laboratories are seeking a collective $1 billion in damages from a major medical-equipment manufacturer they claim sold them faulty gear under false promises.
Accounts receivable (AR) are ballooning to unsustainable levels, and beyond a few informal “blacklisted” groups on social media, no one is talking about the financial chokehold this is putting on the supply chain.
When Maryland Gov. Wes Moore signed a law on April 22 exempting employee stock ownership plans (ESOPs) from the state’s strict five-year license-hold requirement for cannabis businesses, he opened up an exit strategy for founders.
The CEO Mammoth Farms stumbled onto ‘the blueprint for how to launder marijuana’ in and out of the state’s regulated industry, he told MJBizDaily.
Licensed cannabis operators and ancillary companies are bracing for rising business costs, lost customers and vendor backlash in the wake of President Donald Trump’s erratic blanket tariffs that have rattled the global economy and stoked fears of a recession and accelerated inflation in the United States.
